US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Weight Loss Drugs

1,470.07

-22.1052-1.48%

Number of Gainers:4

Number of Losers:3

Number of Flat:- -

PE:- -

High:1,485.06

Open:1,483.83

Low:1,455.39

Close:1,492.17

Loading ...

Amgen Inc. (AMGN) Invests $200M in AI-Focused Tech Center in India, Plans to Hire 2,000 by 2025

AMGEN TO PRESENT AT THE 45TH ANNUAL TD COWEN HEALTH CARE CONFERENCE

Why Pfizer Inc. (PFE) is the Best Vaccine Stock to Buy According to Hedge Funds?

Is Viking Therapeutics, Inc. (VKTX) the Worst Performing Mid Cap Stock to Buy According to Analysts?

Pfizer quietly made some big DEI changes

Eli Lilly takes aim at weight-loss drug copies with new ad campaign

BRIEF-EMA's CHMP Adopts Indication Extension For Abrysvo To Include Adults From 18 Years

Eli Lilly Gets CHMP Backing of Jaypirca in Chronic Lymphocytic Leukemia

Behind Hims Stock's Roller-Coaster Ride As Weight-Loss Drugs Battle Heats Up

Lilly's Jaypirca (pirtobrutinib) recommended by CHMP for approval in the European Union for adults with relapsed or refractory chronic lymphocytic leukemia (CLL) previously treated with a BTK inhibitor

William Blair Initiates Altimmune at Market Perform

MT Newswires Live

Altimmune Initiated at Market Perform by William Blair

Pfizer Updates DEI Webpage to Focus on Merit

MT Newswires Live

UK health regulator approves Moderna's RSV vaccine for adults aged 60 and older

New Treatments Give Hope to Patients With One of the Deadliest Cancers -- WSJ

Bernstein Remains a Hold on Pfizer (PFE)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK4599/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4599"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","market":"US","secType":"PLATE","nameCN":"Weight Loss Drugs","latestPrice":1470.068,"timestamp":1741294799999,"preClose":1492.1732,"halted":0,"volume":66835383,"delay":0,"changeRate":-0.014814,"change":-22.105225,"pbRate":11.780703,"amount":5861497415.910795,"amplitude":0.019884,"prevYearClose":1305.0607,"fiveDayClose":1460.4895,"twentyDayClose":1394.0055,"turnoverRate":0.006332,"marketCap":1580708443232,"floatMarketCap":1468183266688,"peRate":41.703544},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4599\",,,,,undefined,":{"symbol":"BK4599","high":1485.0612,"amplitude":0.019884,"preClose":1492.1732,"low":1455.3911,"pbRate":"11.780703","latestPrice":1470.068,"volume":66835383,"delay":0,"open":1483.8325,"prevYearClose":1305.0607,"prevWeekClose":1482.1702,"prevMonthClose":1482.1702,"prevQuarterClose":1305.0607,"fiveDayClose":1460.4895,"twentyDayClose":1394.0055,"sixtyDayClose":1438.0239,"secType":"PLATE","market":"US","turnoverRate":0.006332,"peRate":41.703544,"marketCap":1580708443232,"floatMarketCap":1468183266688,"timestamp":1741294799999,"nameCN":"Weight Loss Drugs"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4599\",,,,undefined,":{"bkCode":"BK4599","up":4,"down":3,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4599\",pageSize:16,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2516466300","title":"Amgen Inc. (AMGN) Invests $200M in AI-Focused Tech Center in India, Plans to Hire 2,000 by 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2516466300","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516466300?lang=en_us&edition=fundamental","pubTime":"2025-03-01 06:37","pubTimestamp":1740782264,"startTime":"0","endTime":"0","summary":"We recently compiled a list of the 18 AI News and Ratings Making Waves on Wall Street.In this article, we are going to take a look at where Amgen Inc.  stands against the other AI stocks.In a recent discussion at CNBC's 'Squawk on the Street', NYU professor and AI expert, Gary Marcus shared his perspective on the limitations of current AI models, the hurdles in enterprise adoption, and the financial sustainability of major AI companies. His insights raise important questions about the future of AI and whether it can truly deliver on its ambitious promises.AI’s Future Faces Hurdles in Reliability, Costs, and Enterprise Use. At Insider Monkey we are obsessed with the stocks that hedge funds pile into. The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stock","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/amgen-inc-amgn-invests-200m-223744169.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4534","IE00B2B36J28.USD","TSYW.SI","SQQQ","MNQmain","IE00BJT1NW94.SGD","LU2242646821.SGD","BK4533","IE00BFTCPJ56.SGD","NVIW.SI","LU1061106388.HKD","QLD","BK4599","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","TQQQ","LU1571399168.USD","QID","USJW.SI","LU1057294990.SGD","USAW.SI","LU0109394709.USD","IE0002141913.USD","LU0320765992.SGD","LU0889565916.HKD","LU1023059063.AUD","LU0122379950.USD","BK4139","AMGN","BK4585","LU0058720904.USD","BK4588","IE0009355771.USD","NQmain","LU0289739699.SGD","LU0868494617.USD","PSQ","LU2112291526.USD","BK4566","LU2242652126.USD","LU1983299246.USD",".IXIC","SG9999001440.SGD","BK4581"],"gpt_icon":1},{"id":"2516830105","title":"AMGEN TO PRESENT AT THE 45TH ANNUAL TD COWEN HEALTH CARE CONFERENCE","url":"https://stock-news.laohu8.com/highlight/detail?id=2516830105","media":"PR Newswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516830105?lang=en_us&edition=fundamental","pubTime":"2025-03-01 05:01","pubTimestamp":1740776460,"startTime":"0","endTime":"0","summary":"THOUSAND OAKS, Calif., Feb. 28, 2025 /PRNewswire/ --Amgen  will present at the 45th Annual TD Cowen Health Care Conference at 9:10 a.m. ET on Wednesday, March 5, 2025. Jay Bradner, executive vice president of Research and Development at Amgen, will participate in a fireside chat at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com, under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.For more information, visit Amgen.comand follow us on X, LinkedIn, Instagram,YouTubeand Threads.CONTA","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/amgen-present-45th-annual-td-210100755.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/amgen-present-45th-annual-td-210100755.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1057294990.SGD","IE00BFTCPJ56.SGD","COWN","BK4139","LU1571399168.USD","LU0058720904.USD","IE0002141913.USD","LU1061106388.HKD","LU2242646821.SGD","AMGN","BK4534","SG9999001440.SGD","IE00BJJMRZ35.SGD","LU0289739699.SGD","CARE","LU0889565916.HKD","LU1023059063.AUD","IE00B2B36J28.USD","BK4211","BK4533","IE0009355771.USD","LU2242652126.USD","BK4207","BK4581","TD","LU2112291526.USD","LU0868494617.USD","LU0320765992.SGD","LU0122379950.USD","BK4599","LU0109394709.USD","BK4585","IE00B4R5TH58.HKD","BK4566","BK4127","LU1983299246.USD","BK4588","IE00BJT1NW94.SGD"],"gpt_icon":0},{"id":"2516720943","title":"Why Pfizer Inc. (PFE) is the Best Vaccine Stock to Buy According to Hedge Funds?","url":"https://stock-news.laohu8.com/highlight/detail?id=2516720943","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516720943?lang=en_us&edition=fundamental","pubTime":"2025-03-01 01:31","pubTimestamp":1740763919,"startTime":"0","endTime":"0","summary":"We recently published a list of the 10 Best Vaccine Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Pfizer Inc.  stands against the other best vaccine store stocks to buy now.What Will Trump’s Tariffs Mean for the Pharma Industry?On February 24, CNBC reported that President Trump declared that sweeping US tariffs on imports from Mexico and Canada “will go forward” in a statement before the expiry of their month-long delay on their implementation. When asked about the postponed tariffs at a White House press conference, President Trump said:. “The tariffs are going forward on time, on schedule.”He claimed that foreign nations have been taking advantage of the US in “just about everything,” reiterating his plans to impose “reciprocal tariffs.”“So the tariffs will go forward, yes, and we’re going to make up a lot of territory,” Trump said.READ ALSO:10 Best Performing Pharma Stocks So Far in 2025and10 Oversold Pharma Stocks to Buy According to ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/why-pfizer-inc-pfe-best-173159236.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","LU1894683348.USD","BK4568","IE000M9KFDE8.USD","SG9999001176.USD","SGXZ57979304.SGD","LU0225771236.USD","SG9999003800.SGD","BK4585","BK4599","LU0321505868.SGD","SG9999001176.SGD","SG9999002224.SGD","LU0170899867.USD","LU0306806265.USD","LU1057294990.SGD","LU1894683264.USD","SG9999013999.USD","BK4592","LU0985481810.HKD","IE0002270589.USD","LU1066053197.SGD","LU1883839398.USD","LU0122379950.USD","LU0225284248.USD","IE00BLSP4452.SGD","LU1066051498.USD","IE00BBT3K403.USD","BK4581","BK4534","LU0868494617.USD","BK4588","LU0058720904.USD","BK4550","IE00B19Z3581.USD","LU0306807586.USD","LU0456855351.SGD","IE00BLSP4239.USD","LU0234572021.USD","LU0321505439.SGD","LU0289739699.SGD","LU1023059063.AUD","IE00B19Z3B42.SGD","SG9999002232.USD","SG9999011175.SGD","BK4533","PFE"],"gpt_icon":1},{"id":"2516810377","title":"Is Viking Therapeutics, Inc. (VKTX) the Worst Performing Mid Cap Stock to Buy According to Analysts?","url":"https://stock-news.laohu8.com/highlight/detail?id=2516810377","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516810377?lang=en_us&edition=fundamental","pubTime":"2025-03-01 01:30","pubTimestamp":1740763822,"startTime":"0","endTime":"0","summary":"We recently published a list of 10 Worst Performing Mid Cap Stocks to Buy According to Analysts. In this article, we are going to take a look at where Viking Therapeutics, Inc.  stands against other worst performing mid cap stocks to buy according to analysts.Hall highlighted that interest rates still play a crucial role in market dynamics. Bank of America’s economists expect the Fed to maintain its current stance without further cuts, which could pose refinancing risks for small caps. Mid-caps, on the other hand, have better balance sheets and fundamental trends, which positions them more favorably. Despite the optimism around economic policies and potential deregulation, Hall noted that small caps face a high bar for investor confidence after a decade of underperformance. Historically, small caps are due for an outperformance cycle, and relative valuations suggest they could offer the best price returns over the next decade. However, for this year, investors are cautious about reente","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/viking-therapeutics-inc-vktx-worst-173022728.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TQQQ",".IXIC","NQmain","TSYW.SI","BK4585","MNQmain","NVIW.SI","BK4588","SQQQ","BK4139","USAW.SI","USJW.SI","PSQ","QLD","QID","VKTX","BK4599"],"gpt_icon":1},{"id":"2516637209","title":"Pfizer quietly made some big DEI changes","url":"https://stock-news.laohu8.com/highlight/detail?id=2516637209","media":"Quartz","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516637209?lang=en_us&edition=fundamental","pubTime":"2025-03-01 00:29","pubTimestamp":1740760140,"startTime":"0","endTime":"0","summary":"Pfizer logo is seen on Pfizer World Headquarters in Manhattan, New York, United States of America, on July 6th, 2024. - Image: NurPhoto / Contributor . Pfizer  made some major changes to its diversity, equity, and inclusion  webpage on Thursday, joining other major American corporations that have recently aligned themselves closer with the Trump administration.Other sections of the webpage underwent similar changes. A section previously titled “Diversity in Our Global Supply” has been renamed “Inclusive Supplier Strategy.” The paragraph under this heading now states, “All areas of our business groups are dedicated to finding and selecting the best suppliers,” replacing the previous language that emphasized advancing DEI.Pfizer did not immediately respond to a request for comment from Quartz. However, a company spokesperson told STAT News, which first reported the changes, “We constantly update and evolve the content and design of our website to reflect our current programs, initiatives","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/pfizer-quietly-made-big-dei-162900503.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","LU0096364046.USD","LU0417517546.SGD","IE00BJLML261.HKD","JNJ","LU0094547139.USD","LU1323610961.USD","BK4599","SG9999002224.SGD","LU1057294990.SGD","LU1430594728.SGD","IE00BVYPNV92.GBP","LU2491050154.USD","LU2242652126.USD","LU0109391861.USD","LU1066053197.SGD","LU1883839398.USD","PFE","LU0238689110.USD","LU0882574055.USD","LU1670710661.SGD","LU0471298694.HKD","BIIB","SGXZ81514606.USD","IE00BLSP4452.SGD","LU1066051498.USD","LU0868494617.USD","BK4581","DEI","LU1093756168.USD","LU2361045086.USD","LU2265009873.SGD","LU2129689514.USD","SG9999014898.SGD","LU0203345920.USD","BMY","LU0061475181.USD","LU1868836757.USD","LU0306807586.USD","IE00BVYPNW00.USD","LU1712237335.SGD","LU2133065610.SGD","LU0289739699.SGD","BK4223","LU1674673691.USD","SG9999001440.SGD","BK4504","BK4532","SG9999018857.SGD"],"gpt_icon":1},{"id":"2514778378","title":"Eli Lilly takes aim at weight-loss drug copies with new ad campaign","url":"https://stock-news.laohu8.com/highlight/detail?id=2514778378","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514778378?lang=en_us&edition=fundamental","pubTime":"2025-02-28 23:00","pubTimestamp":1740754800,"startTime":"0","endTime":"0","summary":"Eli Lilly takes aim at weight-loss drug copies with new ad campaignFeb 28 (Reuters) - Eli Lilly LLY.N launched an ad campaign on Friday, cautioning patients against the risks of unapproved weight-loss","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250228:nL3N3PI21C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015945.SGD","SG9999015952.SGD","SG9999001176.USD","LU0006306889.USD","LU0203202063.USD","LU1548497426.USD","IE0002141913.USD","LU1917777945.USD","IE00BJLML261.HKD","LU0943347566.SGD","SG9999013999.USD","LU0640476718.USD","IE00B1BXHZ80.USD","LU1291159041.SGD","IE0004445239.USD","IE00BK4W5L77.USD","LU2211815571.USD","LU0456855351.SGD","IE00BFTCPJ56.SGD","SGXZ99366536.SGD","LU1814569148.SGD","LU0820561818.USD","LU1868837300.USD","LU0109391861.USD","LU0417517546.SGD","LU0058720904.USD","SG9999014880.SGD","SG9999001176.SGD","BK4007","LU0708995401.HKD","LU2360106947.USD","LU2361044865.SGD","SG9999018857.SGD","LU1988902786.USD","LLY","SG9999014906.USD","IE00BK4W5M84.HKD","SGXZ31699556.SGD","BK4588","GB00BDT5M118.USD","LU1983299246.USD","LU2237443895.HKD","LU2237443978.SGD","IE00B4R5TH58.HKD","LU0471298694.HKD","LU1804176565.USD","LU2237443465.HKD","LU2491049909.HKD","BK4599"],"gpt_icon":1},{"id":"2514205263","title":"BRIEF-EMA's CHMP Adopts Indication Extension For Abrysvo To Include Adults From 18 Years","url":"https://stock-news.laohu8.com/highlight/detail?id=2514205263","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514205263?lang=en_us&edition=fundamental","pubTime":"2025-02-28 22:36","pubTimestamp":1740753379,"startTime":"0","endTime":"0","summary":"BRIEF-EMA's CHMP Adopts Indication Extension For Abrysvo To Include Adults From 18 YearsFeb 28  - EMA's CHMP:CHMP ADOPTED EXTENSION TO EXISTING INDICATION TO EXTEND USE OF ABRYSVO TO ADULTS FROM 18 YEARS OF AGESource text: [ID:]Further company coverage: PFE.N ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250228:nFWN3PJ12L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1894683348.USD","BK4592","LU0170899867.USD","LU0321505439.SGD","LU0456855351.SGD","PFE","IE00B19Z3B42.SGD","BK4534","IE0002270589.USD","LU0321505868.SGD","LU0306806265.USD","BK4533","SG9999001176.SGD","IE00BBT3K403.USD","BK4581","BK4599","BK4007","SG9999002232.USD","SG9999011175.SGD","BK4550","LU0225771236.USD","LU0234572021.USD","SG9999001176.USD","LU1883839398.USD","LU1057294990.SGD","LU0225284248.USD","LU0985481810.HKD","IE00B19Z3581.USD","SG9999013999.USD","SG9999002224.SGD","LU1023059063.AUD","LU0122379950.USD","LU1066051498.USD","BK4585","LU0058720904.USD","BK4588","SGXZ57979304.SGD","IE00BLSP4452.SGD","BK4568","SG9999003800.SGD","LU0289739699.SGD","LU0868494617.USD","LU1894683264.USD","LU1066053197.SGD","IE00BLSP4239.USD","IE000M9KFDE8.USD","LU0306807586.USD"],"gpt_icon":0},{"id":"2514732264","title":"Eli Lilly Gets CHMP Backing of Jaypirca in Chronic Lymphocytic Leukemia","url":"https://stock-news.laohu8.com/highlight/detail?id=2514732264","media":"Dow Jones","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514732264?lang=en_us&edition=fundamental","pubTime":"2025-02-28 21:59","pubTimestamp":1740751140,"startTime":"0","endTime":"0","summary":"Eli Lilly said the European Medicines Agency's Committee for Medicinal Products for Human Use has recommended expanded approval of its Jaypirca cancer drug in certain patients with chronic lymphocytic leukemia.Eli Lilly on Friday said the recommendation covers Jaypirca for the treatment of adults with relapsed or refractory chronic lymphocytic leukemia who have been previously treated with a Bruton's tyrosine kinase inhibitor.The Indianapolis drugmaker said the European Commission, which generally follows the CHMP's advice, is expected to make a final decision in the next one to two months.Eli Lilly previously won conditional European approval for Jaypirca in adults with relapsed or refractory mantle cell lymphoma who have been previously treated with a BTK inhibitor.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999018857.SGD","LU0456855351.SGD","SG9999018865.SGD","SG9999001176.SGD","LU1868837300.USD","SG9999015945.SGD","LU1623119135.USD","LU0417517546.SGD","LU1035775433.USD","LU2237443622.USD","IE0002141913.USD","LU1720051017.SGD","BK4585","LU1061106388.HKD","SG9999014906.USD","LU1989771016.USD","SG9999013999.USD","BK4534","LU0096364046.USD","LU0238689110.USD","LU2361045086.USD","LU2264538146.SGD","LU2324357040.USD","LU1983299246.USD","LU2237443382.USD","LU1974910355.USD","LU0882574139.USD","LU2106854487.HKD","LU2602419157.SGD","LU1917777945.USD","LU1093756325.SGD","LU0354030438.USD","LU1868836757.USD","LU0708995401.HKD","LU2361044949.HKD","LU0672654240.SGD","SGXZ81514606.USD","LU0256863902.USD","LU0203202063.USD","LU1023059063.AUD","CHMP","LLY","SGXZ51526630.SGD","SG9999015986.USD","LU0079474960.USD","LU0466842654.USD","LU0106261372.USD","BK4599","IE00BK4W5M84.HKD","LU2089984988.USD"],"gpt_icon":1},{"id":"2514375462","title":"Behind Hims Stock's Roller-Coaster Ride As Weight-Loss Drugs Battle Heats Up","url":"https://stock-news.laohu8.com/highlight/detail?id=2514375462","media":"Blockhead","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514375462?lang=en_us&edition=fundamental","pubTime":"2025-02-28 21:30","pubTimestamp":1740749453,"startTime":"0","endTime":"0","summary":"Hims & Hers Health put out a jaw dropping commercial. Now, Hims stock is just dropping, as its semaglutide business faces a setback.","market":"sg","thumbnail":"https://www.investors.com/wp-content/uploads/2025/02/TECH1_himshers_022825-150x150.jpg","type":0,"news_type":0,"thumbnails":["https://www.investors.com/wp-content/uploads/2025/02/TECH1_himshers_022825-150x150.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.investors.com/news/technology/hims-stock-hims-hers-health-semaglutide-shortage/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"investor_business_daily_highlight","symbols":["LU1868837136.USD","LU0640476718.USD","SG9999014914.USD","LU1291159041.SGD","LU0820561909.HKD","LU1548497426.USD","LU2461242641.AUD","IE00BJT1NW94.SGD","LU0354030511.USD","LU1917777945.USD","LU2089984988.USD","SG9999001176.SGD","SG9999014906.USD","LU0006306889.USD","SG9999015945.SGD","IE00B1BXHZ80.USD","LU1814569148.SGD","SG9999018857.SGD","LU0471298694.HKD","LLY","SG9999017495.SGD","LU0203201768.USD","LU0094547139.USD","IE00BZ1G4Q59.USD","LU1974910355.USD","LU0238689110.USD","LU1064131342.USD","BK4534","LU1988902786.USD","SG9999015986.USD","HIMS","LU2602419157.SGD","NVO","LU0058720904.USD","NVO.AU","BK4516","LU0079474960.USD","LU2265009873.SGD","SGXZ57979304.SGD","BK4599","LU2361045086.USD","BK4007","IE00BJLML261.HKD","IE00BKVL7J92.USD","LU0466842654.USD","IE00BK4W5L77.USD","LU0096364046.USD","LU0320765059.SGD","LU0106261372.USD","LU1804176565.USD"],"gpt_icon":0},{"id":"2514324925","title":"Lilly's Jaypirca (pirtobrutinib) recommended by CHMP for approval in the European Union for adults with relapsed or refractory chronic lymphocytic leukemia (CLL) previously treated with a BTK inhibitor","url":"https://stock-news.laohu8.com/highlight/detail?id=2514324925","media":"PR Newswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514324925?lang=en_us&edition=fundamental","pubTime":"2025-02-28 21:14","pubTimestamp":1740748440,"startTime":"0","endTime":"0","summary":"The positive opinion is based on results from the Phase 3 BRUIN CLL-321 trial, recently presented at the 2024 American Society of Hematology Annual Meeting. BRUIN CLL-321 is the first randomized Phase 3 study in CLL ever conducted exclusively in patients previously treated with a BTK inhibitor. The positive opinion is supported by data from the BRUIN CLL-321 clinical trial, the first randomized Phase 3 study in CLL ever conducted exclusively in patients previously treated with a BTK inhibitor. The study's primary endpoint of progression-free survival  was met at the prespecified time of final analysis , based on independent review committee  assessment, demonstrating pirtobrutinib was superior to investigator's choice of idelalisib plus rituximab  or bendamustine plus rituximab , both global standards of care.1 At an updated analysis , pirtobrutinib reduced therisk of disease progressionor death by 46% compared to IdelaR or BR, consistent with the primary analysis.PFS results were cons","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/lillys-jaypirca-pirtobrutinib-recommended-chmp-131400700.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/lillys-jaypirca-pirtobrutinib-recommended-chmp-131400700.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE0002141913.USD","LU1814569148.SGD","LU1974910355.USD","PRO","LU2211815571.USD","BK4094","LU0203202063.USD","LU1720051108.HKD","BK4585","LU2237443978.SGD","FL","LU1061106388.HKD","LU2265009873.SGD","ASH","LU2361045086.USD","LU2491050071.SGD","CHMP","IE0009355771.USD","LU2063271972.USD","LU2237443382.USD","SG9999001176.USD","LU1267930730.SGD","LU0390134368.USD","LU2237443622.USD","BNTX","LU0203201768.USD","BK4599","LU2602419157.SGD","BK4109","BK4516","LU2461242641.AUD","ORR","BK4533","BK4588","BR","LU0640476718.USD","BK4226","LU2237443465.HKD","SG9999015986.USD","LU1023059063.AUD","LU0471298777.SGD","IE00BK4W5L77.USD","IE00BJT1NW94.SGD","LLY","LU0354030511.USD","LU1069344957.HKD","LU0882574139.USD","LU0238689110.USD","PFS","OS"],"gpt_icon":1},{"id":"2514326063","title":"William Blair Initiates Altimmune at Market Perform","url":"https://stock-news.laohu8.com/highlight/detail?id=2514326063","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514326063?lang=en_us&edition=fundamental","pubTime":"2025-02-28 20:50","pubTimestamp":1740747015,"startTime":"0","endTime":"0","summary":"Altimmune (ALT) has an average rating of buy and mean price target of $22.38, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4599","LU1878469433.USD","BK4139","ALT"],"gpt_icon":0},{"id":"2514325429","title":"Altimmune Initiated at Market Perform by William Blair","url":"https://stock-news.laohu8.com/highlight/detail?id=2514325429","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514325429?lang=en_us&edition=fundamental","pubTime":"2025-02-28 20:24","pubTimestamp":1740745440,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ALT/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 28, 2025 07:24 ET (12:24 GMT)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1878469433.USD","BK4599","ALT","BK4139"],"gpt_icon":0},{"id":"2514328449","title":"Pfizer Updates DEI Webpage to Focus on Merit","url":"https://stock-news.laohu8.com/highlight/detail?id=2514328449","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514328449?lang=en_us&edition=fundamental","pubTime":"2025-02-28 19:49","pubTimestamp":1740743395,"startTime":"0","endTime":"0","summary":"Pfizer (PFE) revised its diversity, equity, and inclusion webpage Thursday to focus on merit, reflecting broader adjustments by companies in response to the Trump administration's rollback of DEI poli","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4550","IE0002270589.USD","LU1023059063.AUD","IE00BLSP4452.SGD","IE00BBT3K403.USD","BK4194","BK4534","LU0122379950.USD","LU1894683264.USD","BK4592","IE00BLSP4239.USD","BK4588","LU1894683348.USD","LU0289739699.SGD","LU0868494617.USD","LU1066053197.SGD","SG9999013999.USD","LU1057294990.SGD","SG9999002224.SGD","SG9999011175.SGD","LU0321505439.SGD","BK4007","IE00B19Z3581.USD","LU0306806265.USD","LU1066051498.USD","LU0321505868.SGD","BK4585","LU1883839398.USD","LU0170899867.USD","LU0306807586.USD","LU0225284248.USD","BK4223","BK4581","IE00B19Z3B42.SGD","SG9999003800.SGD","IE000M9KFDE8.USD","PFE.AU","BK4568","DEI","LU0058720904.USD","BK7095","SGXZ57979304.SGD","SG9999001176.USD","LU0225771236.USD","LU0456855351.SGD","PFE","BK4533","BK4599","LU0985481810.HKD","LU0234572021.USD"],"gpt_icon":1},{"id":"2514347556","title":"UK health regulator approves Moderna's RSV vaccine for adults aged 60 and older","url":"https://stock-news.laohu8.com/highlight/detail?id=2514347556","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514347556?lang=en_us&edition=fundamental","pubTime":"2025-02-28 19:07","pubTimestamp":1740740878,"startTime":"0","endTime":"0","summary":"UPDATE 1-UK health regulator approves Moderna's RSV vaccine for adults aged 60 and olderAdds details on vaccine in paragraph 2, details on disease in paragraphs 3 & 4Feb 28  - Britain's health regulator said on Friday it has approved Moderna's MRNA.O vaccine for respiratory syncytial virus in adults 60 years and older. The shot, branded as mRESVIA, is for the prevention of lower respiratory tract disease in older adults, the Medicines and Healthcare products Regulatory Agency  said.RSV is a common virus that spreads very easily and causes infections that can be mild, with cold-like symptoms, but can also cause more serious problems, such as lung infections and pneumonia.Older adults are at risk of more serious complications that could lead to hospital admission and even death.GSK's GSK.L vaccine Arexvy and Pfizer's <PFE.N> shot Abrysvo are approved for use in individuals over the age of 60 in the UK.  ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250228:nL3N3PJ0V0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK5011","LU1481600234.SGD","BK4139","LU0234572021.USD","LU0306806265.USD","IE00BLSP4452.SGD","LU1066051498.USD","GSK.UK","SG9999002232.USD","IE00BBT3K403.USD","IE0034235071.USD","LU0289739699.SGD","BK4585","BK4592","BK4550","BK4599","LU0985481810.HKD","LU1894683264.USD","LU1302929846.USD","LU0203347892.USD","LU1035777561.USD","LU1645745479.HKD","LU1481599808.USD","MRNA","LU1883839398.USD","LU1015430645.USD","LU0971552830.HKD","LU1400636491.USD","IE0002270589.USD","LU1057294990.SGD","LU1228905037.USD","LU1228905540.USD","IE00BWDBJ516.SGD","SG9999001176.USD","LU0203345920.USD","IE00BLSP4239.USD","BK4581","BK4534","LU0545562505.USD","LU1202635105.USD","BK4007","BK4588","SG9999001176.SGD","BK4568","LU1064927863.SGD","LU1400636574.HKD","BK4548","LU0225771236.USD","BK4532"],"gpt_icon":1},{"id":"2514344899","title":"New Treatments Give Hope to Patients With One of the Deadliest Cancers -- WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2514344899","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514344899?lang=en_us&edition=fundamental","pubTime":"2025-02-28 18:30","pubTimestamp":1740738600,"startTime":"0","endTime":"0","summary":"By Brianna Abbott | Photographs by Helynn Ospina for WSJ. Pranathi Perati was running out of time to treat her stage-four pancreatic cancer when she found out she would get another shot: a clinical trial testing a new experimental drug.Perati's odds were slim -- only 3% of late-stage pancreatic cancer patients are still alive after five years. And half of all pancreatic cancer patients live for less than a year after their diagnosis. For Perati, the drug, daraxonrasib from Revolution Medicines, has helped keep her alive for 17 months and counting.Pancreatic cancer is one of the toughest cancers to treat. Often caught late, it kills nearly 52,000 people in the U.S. each year, making it the country's third leading cause of cancer death, behind lung and colorectal. Case rates have gradually increased, particularly among younger women, in part because of rising obesity rates.Researchers believe that could change with newer therapies, particularly those that target KRAS. The gene acts as a ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","SGXZ57979304.SGD","LU0321505868.SGD","LU0058720904.USD","BK4581","LU0225284248.USD","LU0234572021.USD","LU1023059063.AUD","LU0170899867.USD","LU1057294990.SGD","BK4568","LU1066053197.SGD","LU1894683348.USD","IE00BBT3K403.USD","LU0306807586.USD","SG9999002232.USD","LU1883839398.USD","IE00B19Z3B42.SGD","SG9999011175.SGD","IE00B19Z3581.USD","BK4599","SG9999002224.SGD","IE00BLSP4452.SGD","SG9999003800.SGD","BK4533","BK4550","LU1894683264.USD","IE0002270589.USD","LU0985481810.HKD","BK4588","BK4592","IE000M9KFDE8.USD","LU0225771236.USD","BK4007","BK4211","PFE","LU0306806265.USD","SG9999001176.SGD","LU1066051498.USD","LU0289739699.SGD","HOPE","LU0321505439.SGD","IE00BLSP4239.USD","SG9999013999.USD","SG9999001176.USD","LU0456855351.SGD","LU0122379950.USD","LU0868494617.USD","BK4585"],"gpt_icon":0},{"id":"2514411973","title":"Bernstein Remains a Hold on Pfizer (PFE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2514411973","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514411973?lang=en_us&edition=fundamental","pubTime":"2025-02-28 18:16","pubTimestamp":1740737777,"startTime":"0","endTime":"0","summary":"Bernstein analyst Courtney Breen maintained a Hold rating on Pfizer (PFE – Research Report) yesterday and set a price target of $30.00. The company...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bernstein-remains-a-hold-on-pfizer-pfe-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bernstein-remains-a-hold-on-pfizer-pfe-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1057294990.SGD","PFE","LU0234572021.USD","SG9999011175.SGD","LU0225284248.USD","LU0058720904.USD","LU0985481810.HKD","BK4550","BK4568","BK4007","LU0306806265.USD","IE00BLSP4239.USD","SG9999013999.USD","BK4534","IE00BBT3K403.USD","LU0289739699.SGD","LU0306807586.USD","LU1066053197.SGD","SG9999002232.USD","LU1023059063.AUD","SG9999001176.SGD","LU0225771236.USD","LU1894683264.USD","SG9999003800.SGD","IE00BLSP4452.SGD","BK4533","IE00B19Z3581.USD","IE000M9KFDE8.USD","LU1894683348.USD","IE00B19Z3B42.SGD","LU0321505439.SGD","BK4581","LU0868494617.USD","LU0456855351.SGD","LU0122379950.USD","BK4599","SGXZ57979304.SGD","BK4585","LU0321505868.SGD","SG9999001176.USD","SG9999002224.SGD","BK4588","LU0170899867.USD","IE0002270589.USD","BK4592","LU1066051498.USD","LU1883839398.USD"],"gpt_icon":0}],"pageSize":16,"totalPage":16,"pageCount":7,"totalSize":243}]}}